home / stock / mdwd / mdwd news


MDWD News and Press, MediWound Ltd. From 12/28/23

Stock Information

Company Name: MediWound Ltd.
Stock Symbol: MDWD
Market: NASDAQ
Website: mediwound.com

Menu

MDWD MDWD Quote MDWD Short MDWD News MDWD Articles MDWD Message Board
Get MDWD Alerts

News, Short Squeeze, Breakout and More Instantly...

MDWD - MediWound wins DoD funding to develop NexoBrid for U.S. Army

2023-12-28 07:20:44 ET More on MediWound, Vericel, etc. MediWound Ltd. (MDWD) Q3 2023 Earnings Call Transcript Vericel Corporation (VCEL) Q3 2023 Earnings Call Transcript Vericel Corporation 2023 Q3 - Results - Earnings Call Presentation 3M to join MediWound ...

MDWD - MediWound Announces Peer-Reviewed Publication of EscharEx® Mechanism of Action Study Assessing Its Effects on Biofilm and Microbial Loads

YAVNE, Israel, Dec. 21, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair today announced the publication of a peer-reviewed paper, titled “ An Open-label, Proof of Concept Study, Assessing the Effects of...

MDWD - Mediwound Ltd. ($MDWD) Trading Report

2023-12-18 01:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

MDWD - MediWound Ltd. (MDWD) Q3 2023 Earnings Call Transcript

2023-11-21 13:14:09 ET MediWound Ltd. (MDWD) Q3 2023 Earnings Call Transcript November 21, 2023 08:30 AM ET Company Participants Daniel Ferry - LifeSci Advisors Ofer Gonen - Chief Executive Officer Barry Wolfenson - Executive Vice President of Strategy & Corp...

MDWD - MediWound GAAP EPS of -$0.24 beats by $0.16, revenue of $4.77M beats by $0.02M

2023-11-21 07:05:36 ET More on MediWound 3M to join MediWound in Phase 3 trial for wound care product MediWound burn therapy NexoBrid launched in US Seeking Alpha’s Quant Rating on MediWound Historical earnings data for MediWound Financial info...

MDWD - MediWound Reports Third Quarter 2023 Financial Results and Provides Company Update

NexoBrid ® commercially launched in U.S. and Japan; Company prioritizes operational resources to meet increased global demand EscharEx ® Phase III study preparations progressing; Protocol submission to FDA expected in first quarter 2024 Cash of $46 million; Opera...

MDWD - MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer

YAVNE, Israel, Nov. 21, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today announced the appointment of Shmulik Hess, Ph.D. to the positions of Chief Operating Officer and ...

MDWD - Expected US Company Earnings on Tuesday, November 21st, 2023

Freightos Limited (CRGO) is expected to report $-0.14 for Q3 2023 Magyar Telekom Telecommunications ADR (MYTAY) is expected to report for Q3 2023 IMAC Holdings Inc. (BACK) is expected to report for Q1 2024 NewJersey Resources Corporation (NJR) is expected to report $0.3 for Q4 2023 ...

MDWD - Expected earnings - MediWound Ltd.

MediWound Ltd. (MDWD) is expected to report $-0.45 for Q3 2023

MDWD - MediWound Q3 2023 Earnings Preview

2023-11-20 12:56:52 ET More on MediWound 3M to join MediWound in Phase 3 trial for wound care product MediWound burn therapy NexoBrid launched in US Seeking Alpha’s Quant Rating on MediWound Historical earnings data for MediWound Financial info...

Previous 10 Next 10